Marktgröße für onkolytische Virusimmuntherapie, Anteilsanalyse bis 2025-2031
Oncolytic Virus Immunotherapy Market Report Analysis
Oncolytic Virus Immunotherapy Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Amgen, Inc.
- Merck KGaA
- Shanghai Sunway Biotech Co. Ltd.
- TILT Biotherapeutics
- Oncorus, Inc.
- Oncolys BioPharma, Inc.
- Sorrento Therapeutics, Inc.
- Oncolytics Biotech, Inc.
- SillaJen, Inc.
Regional Overview
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Mittlerer Osten und Afrika
Market Segmentation
By Virustyp
- Herpes-simplex-Virus
- Vaccinia-Virus
- Adenovirus
- Reovirus
- andere
By Verabreichungsweg
- intratumoral
- intravenös
By Anwendung
- Melanom
- nicht-kleinzelliger Lungenkrebs
By Geographie
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
Get Free Sample For